Results

Total Results: over 10,000 records

Showing results for "discussed".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
    January 01, 2005 - A-1 Appendix: Test Performance Metrics The basic definitions of test performance are based upon a 2×2 cross tabulation of the “true disease status” and the test results (Appendix Table). Ostensibly simple, the information in a 2×2 table can be summarized in several ways—some of which are mathematically equivale…
  2. www.ahrq.gov/hai/cusp/clabsi-final/clabsifinalap.html
    January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Final Report Appendix A: Interview Questions Previous Page   Table of Contents Eliminating CLABSI, A National Patient Safety Imperative: Final Report Executive Summary Report Organization Program Implementation Program Impact What W…
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_research-protocol.pdf
    December 09, 2009 - Questions about the minimum age was discussed.
  4. digital.ahrq.gov/sites/default/files/docs/citation/r21hs023849-valdez-final-report-2018.pdf
    January 01, 2018 - For example, many populations have discussed the need for tools that facilitate interaction with social
  5. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017017-logan-final-report-2009.pdf
    January 01, 2009 - • Timing of measurement: Temporal issues also arose when physicians discussed measures they
  6. www.ahrq.gov/downloads/pub/prevent/pdfser/cas/cases.pdf
    December 01, 2007 - Abstracts that were selected by fewer than three reviewers were discussed and selected based on consensus … and KQ4 were examined for demographic and co-morbidity subanalyses; the methods of these studies are discussed … hematoma 2% pneumonia Data collected from medical record and claims database Reviewer blinding not discussed … 2.7% 1996-97 = 2.2% Reviewer not blinded to treatment, hospital course Loss to follow-up not discussed
  7. cdsic.ahrq.gov/sites/default/files/2023-09/TPC_Codesign%20Report%20to%20AHRQ%20FINAL.pdf
    January 01, 2023 - Trust & Patient-centeredness Workgroup: Methods for Involving End-users in PC CDS Co-design Trust & Patient-centeredness Workgroup: Methods for Involving End-users in PC CDS Co-design Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No:…
  8. cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
    December 01, 2018 - As a result, query results likely include a fraction of the care discussed with a patient. … semi-structured representation of the Pain Management Summary artifact incorporates all enhancements discussed
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/quality-gap-palliative-hospice_research-protocol.pdf
    June 27, 2011 - We discussed areas of focus, which included a number of stakeholder perspectives, with the Technical … If the first and second reviewers (above) cannot come to an agreement, the abstract will be discussed
  10. digital.ahrq.gov/sites/default/files/docs/citation/healthitandlaborders.pdf
    November 01, 2011 - This issue will be discussed in more detail in Section IV, subsection A. … Following each walk-through, staff discussed what worked and what did not, and adjusted workflows accordingly
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
    November 01, 2014 - angiography is less commonly used now as a confirmatory test, harms from it occurred in 2 of the pre- viously discussed … The 3 previously discussed RCTs, 8 studies based on additional trials, and 8 cohort studies provided
  12. www.ahrq.gov/sites/default/files/publications/files/ltcmodule2.pdf
    June 01, 2012 - As a result, things that might affect a resident’s safety may go unreported or not be discussed. … As a result, things that might affect a resident’s safety may go unreported or not be discussed.
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
    March 16, 2017 - The Key Questions Preliminary Key Questions (KQ) and protocol were discussed in depth with a panel of … implement a training session, in which all researchers will screen the same articles and conflicts will be discussed
  14. effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-case-130621.pdf
    June 01, 2013 - These points are discussed in greater detail throughout the document. Table 1. … During this time, the judges discussed their scores and recommended the three winners.
  15. www.ahrq.gov/ncepcr/tools/workforce-financing/white-paper.html
    July 01, 2019 - Determinants of Health PRAPARE survey, health process and outcome metrics compared by race or SES As discussed … For each of the measures discussed above, the frequency, modality, and approach can greatly influence
  16. References (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/subglottic-litreview.docx
    January 01, 2017 - Correspondence re: Lacherade study (Taylor, 2011)11,26 Discussed the validity of the analysis in the … Correspondence re: Lacherade study (Silvestri, 2011)11,27 Discussed the validity of the analysis in
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/RkeQEwKRWULreuWecXG8S-
    July 01, 2013 - Important tradeoffs between the eight programs are discussed. … The biennial comparisons generally show the same differences as discussed before with the triennial
  18. www.ahrq.gov/research/findings/final-reports/iomracereport/reldata3.html
    May 01, 2018 - As discussed later in the chapter, the format used may have implications for Hispanic response rates … White," and instead prefer to identify with a separate, distinct group ( Bailey, 2001 ). 9 Hispanics (discussed
  19. www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening
    July 18, 2023 - transient elevations in liver enzyme or creatine kinase levels is unknown. 1 , 17 In the statin trials discussed … there were no adverse events. 1 , 17 Multifactorial Dyslipidemia The 2 behavioral counseling trials discussed
  20. www.ahrq.gov/patient-safety/reports/liability/pichert.html
    August 01, 2017 - Lessons learned and limitations are discussed. Conclusion . … Details about the PARS intervention process and supporting feedback materials have been published and discussed